Covid vaccine: Pfizer applies for authorisation in US
The vaccine could get emergency approval in the first two weeks of December, officials believe.
Full Article
Covid vaccine: Pfizer applies for authorisation in US
BBC News
0 shares
1 views
You might like
Related news coverage
Moderna asking US, European regulators to greenlight COVID-19 vax
Mid-Day
Moderna Inc, which has reported its Covid-19 vaccine is 94 per cent effective, on Monday announced it is filing with US and..
-
UK regulator set to approve COVID-19 vaccine next week: report
Brisbane Times
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
RHB bullish on glove industry as vaccine deployment could boost global usage by up to 7%
Proactive Investors
-
Pfizer seeking emergency use of its COVID-19 vaccine in US
Mid-Day
Advertisement
More coverage
Pfizer's record breaking 9 month sprint to COVID-19 vaccine: A timeline
Mid-Day
Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent..
-
Pfizer set to apply for US emergency use of its COVID-19 vaccine
SBS
-
Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate
newKerala.com
-
Covid vaccine: Pfizer to apply for authorisation in US
BBC News
-
Pfizer, Moderna COVID-19 vaccine candidates may get EU approval in December
Proactive Investors